Amgen, Jazz Pharma most exposed to recession risk - Seeking Alpha

Discussion in 'Jazz Pharmaceuticals' started by anonymous, Apr 15, 2020 at 1:55 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Bernstein analysts Ronny Gal and Wimal Kapadia contend that Amgen (NASDAQ:AMGN), Jazz Pharmaceuticals (NASDAQ:JAZZ) and UCB SA (OTCPK:UCBJF) are the drug makers most exposed to a recession and spike in unemployment since they have a larger portion of revenue tied to older medicines, implying headwinds to sales as the unemployed shift from private insurance to public options like Medicaid.
     

  2. anonymous

    anonymous Guest

    Jazz didn’t even develop GHB. There is nothing innovative about the Jazz and Fat Boy Bruce. Such a joke of a company.
     
  3. anonymous

    anonymous Guest


    How’s our stock look?

    sincerely,
    BRuce
     
  4. anonymous

    anonymous Guest

    Poor. Especially compared to truly innovative biotechs.
     
  5. anonymous

    anonymous Guest

    We'll see what Jazz is made of now that they have to actually work for their money. My guess is they'll continue to fall apart due to pure incompetence and arrogance. But hey, doesn't Bruce play a mean jazz piano?